Navigation Links
Synergy Pharmaceuticals to Present Scientific Posters at the Upcoming Gastroenterology Society Meetings in the U.S. and Europe
Date:7/31/2012

ticals Inc.

Synergy is a biopharmaceutical company focused on the development of new drugs to treat gastrointestinal disorders and diseases. Synergy's lead proprietary drug candidate plecanatide is a synthetic analog of the human gastrointestinal (GI) hormone uroguanylin, and functions by activating the guanylate cyclase C receptor on epithelial cells of the GI tract. Synergy completed a Phase I study of plecanatide in healthy volunteers and a Phase IIa clinical trial in chronic idiopathic constipation (CIC) patients. In October, 2011, Synergy initiated dosing of patients in a major Phase II/III clinical trial of plecanatide to treat CIC. Plecanatide is also being developed to treat constipation-predominant irritable bowel syndrome (IBS-C), with the first trial in IBS-C patients planned for the second half of 2012. Synergy's second GC-C agonist SP-333 is currently in pre-clinical development to treat inflammatory bowel diseases. More information is available at http://www.synergypharma.com.

About Plecanatide

Plecanatide is a member of a new class of essentially non-systemic drugs, referred to as guanylate cyclase C (GC-C) agonists, that are currently in development to treat CIC and IBS-C. Plecanatide is a synthetic analog of uroguanylin, a natriuretic hormone that regulates ion and fluid transport in the GI tract. Orally-administered plecanatide binds to and activates GC-C receptors expressed on epithelial cells lining the GI mucosa, resulting in activation of the cystic fibrosis transmembrane conductance regulator (CFTR), and leading to augmented flow of chloride and water into the lumen of the gut. Activation of the GC-C receptor pathway is believed to facilitate bowel movement as well as producing other beneficial physiological responses including improvement in abdominal pain and inflammation. In animal models, oral administration of plecanatide promotes intestinal secretion and also ameliorates GI
'/>"/>

SOURCE Synergy Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
9. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
10. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
11. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ANGELES , FARUM, Denmark and ... On July 31, 2015 the US Food and ... the treatment of Major Depressive Disorder in adult patients who ... in the current episode. TMS is a non-invasive technique for ... in patients suffering from Major Depressive Disorder. The procedure has ...
(Date:8/28/2015)... The report "Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, ... by Region ( North America , ... of the World) - Global Trends and Forecast to 2020", ... at USD 4.62 Billion in 2014 and is projected to ... 7.4% from 2015 to 2020. Browse 77 ...
(Date:8/28/2015)... , August 28, 2015 ... to reach USD 49.12 billion by 2020, growing at ... to a new report by Grand View Research, Inc. ... CAGR of 49.7% from 2014 to 2020. ... aging population along with rising incidences of chronic diseases ...
Breaking Medicine Technology:Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5
(Date:8/29/2015)... ... 29, 2015 , ... It can be uncomfortable to wear ... and sweat. "In order to prevent these problems, I conceived of my design," ... MEN'S UNDERGARMENT provides optimal support for a male’s crotch. It improves comfort for ...
(Date:8/29/2015)... ... 2015 , ... Dr. Tim Novelli, DC., Founder and President of the Patriot ... of the chiropractic field in the military. All too often VA hospitals treat patients ... made available to the VA program over a decade ago, the reality is that ...
(Date:8/29/2015)... , ... August 29, 2015 , ... Next weekend is ... summer (which astronomically, officially ends on September 22nd this year). For IT security personnel, ... hangovers linger on which could prove far more costly than a simple headache. , ...
(Date:8/29/2015)... ... August 29, 2015 , ... People who have heart ... emphysema), or asthma, are at higher risk from wildfire smoke especially in Calgary, ... or heart-rhythm problems (arrhythmia or irregular heartbeat) are also sensitive to air pollution. ...
(Date:8/29/2015)... ... , ... The popular television program VOICES IN AMERICA, hosted by legendary star ... devoting an entire short segment to the subject of diabetes. Diabetes is a debilitating ... daily basis, but recent advancements in medical science may prove to be a significant ...
Breaking Medicine News(10 mins):Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2
... ... public outbursts of Wilson, Williams and West in regards to losses of IQ and Emotional ... ... front of millions of viewers Joe Wilson shouts "you lie, to the president, Serena Williams ...
... ... pleased to announce the formation of The Healthcare Consortium. The mission of the ... healthcare workplace to better serve patients and communities. , ... Chicago, IL (PRWEB) September 28, 2009 -- Ascension ...
... more likely to die than patients with higher incomes. That ... to be published in the December 1, 2009 issue of ... Society. The study,s findings indicate that poor prostate cancer patients ... the previous studies on socioeconomic status (SES) and prostate cancer ...
... ages, macular degeneration rates are expected to swell , SUNDAY, ... vision loss among people older than 60, age-related macular degeneration ... as the U.S. population grows older. , However, a series ... mean that eye specialists will be well-prepared to treat the ...
... Dr. ... ... shortage in Oregon will be among the topics discussed by Dr. Kristine Campbell, executive director ... Thursday, Oct. 15., , , , ,Campbell also will speak about health care policy and ...
... spider may improve erections, researchers say , FRIDAY, Sept. ... novel way to treat erectile dysfunction -- using the ... the Brazilian wandering spider (Phoneutria nigriventer) causes a painful ... lead to impotence, researchers from the United States and ...
Cached Medicine News:Health News:Outbursts: Where did Their IQ points Go and What were They Thinking? 2Health News:Outbursts: Where did Their IQ points Go and What were They Thinking? 3Health News:Outbursts: Where did Their IQ points Go and What were They Thinking? 4Health News:Ascension Health, HCA, North Shore-LIJ Health System, and Lightspeed Research -The Foresight Group announce the formation of The Healthcare Consortium 2Health News:Ascension Health, HCA, North Shore-LIJ Health System, and Lightspeed Research -The Foresight Group announce the formation of The Healthcare Consortium 3Health News:Ascension Health, HCA, North Shore-LIJ Health System, and Lightspeed Research -The Foresight Group announce the formation of The Healthcare Consortium 4Health News:Swiss study finds income affects prostate cancer patients' survival 2Health News:New Treatments Hold Hope for Failing Eyes 2Health News:New Treatments Hold Hope for Failing Eyes 3Health News:George Fox University Hosts Oregon Center for Nursing Director Oct. 15 2Health News:Spider Venom -- The Next Way to Treat Impotence? 2
... Dissectron ultrasonic aspirator, ... ultrasonic surgical aspirator for ... of tissue available only ... Gathers in a very ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm....
Medicine Products: